Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
EMJ GOLD
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
First patients enroll in Bundibugyo Ebola treatment trial
The PARTNERS trial has launched in the DRC as the country continues to battle an outbreak that has already led to more than 1,400 cases.
Read more
EMJ shortlisted for The Drum Awards for Marketing 2026
The European Medical Journal has been shortlisted for The Drum Awards for Marketing 2026, for its interactive digital tool combatting COPD diagnostic delays.
WHO backs first malaria treatment for newborns
Until now, there had been no approved malaria treatment for infants weighing less than 4.5kg.
Oral semaglutide shows promise in paediatric type 2 diabetes
A phase 3 trial has shown efficacy in type 2 diabetes for adolescents, positioning it as a potential first oral solution for this population.
Moderna initiates phase 3 bird flu vaccine trial
A phase 3 study of Moderna’s investigational mRNA-based H5 pandemic influenza vaccine candidate has been initiated.
US court blocks CDC vaccine advisory panel appointments
A US court issued a preliminary injunction last month to freeze ACIP appointments, raising vaccination concerns for the upcoming respiratory disease season.
Eli Lilly acquires Kelonia Therapeutics for $7bn
Lilly will gain access to an experimental cancer therapy for multiple myeloma.
OpenAI launches early drug discovery AI model
OpenAI has launched GPT-Rosalind, a domain-specific AI model aimed at improving efficiency in early-stage drug discovery.
Tirzepatide linked to more lean mass loss than semaglutide
The rivalry between Eli Lilly’s tirzepatide and Novo Nordisk’s semaglutide continues.
Loading posts...
« Previous
1
…
5
6
7
8
9
…
54
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View